BE HEARD Archives - Medical Conferences

Bimekizumab shows sustained 2-year efficacy in hidradenitis suppurativa

Presented By

Prof. Christos Zouboulis, Dessau Medical Center, Germany

Trial

BE HEARD

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 13:22

Presented By

Prof. Alexa Kimball, Harvard Medical School, MA, USA

Trial

Phase 3, BE HEARD I and BE HEARD II

Conference

AAD 2023

Type

Peer-reviewed article

15 May 2023 12:26